Gao Hanlin 4

What Happened Gao Hanlin, Chief Scientific Officer of Fulgent Genetics (FLGT), had 1,331 shares withheld on January 26, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock units. The shares were valued at $27.53 each, totaling $36,642. This was a tax-withholding disposition (code F), not an open-market sale or purchase.

Key Details

• Transaction date: January 26, 2026; filing date: January 28, 2026 (timely Form 4 filing).
• Shares withheld/disposed: 1,331 at $27.53 per share; total value $36,642.
• Transaction code: F — shares withheld to satisfy tax withholding on vested RSUs.
• Footnote: These RSUs were assumed under the Merger Agreement dated November 7, 2022 and were originally reported on a Form 4 filed November 9, 2022.
• Shares owned after the transaction: not specified in the excerpt provided.

Context Withholding shares to cover taxes on vested RSUs is a routine administrative event and does not necessarily indicate the insider is selling additional shares or expressing a view on the company's prospects. The transaction reflects tax obligations triggered by vesting rather than an investment decision.